New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 23, 2024 - The Federal Circuit court issued a temporary injunction halting Lupin and Zydus launch of AB-rated generic versions of Astellas’ Myrbetriq (mirabegron) 25 mg extended-release tablets.
Download PDF
Return to publications
